1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 1,267 results.

Thumbnail for Validation of Baseline Total Metabolic Tumor Volume (TMTV) and Total Lesion Glycolysis (TLG) as Predictors of Early Progression (POD24) in Follicular Lymphoma: A Retrospective Study of 100 Patients in Brazil

IBCL - 1459

Validation of Baseline Total Metabolic Tumor Volume (TMTV) and Total Lesion Glycolysis (TLG) as Predictors of Early Progression (POD24) in Follicular Lymphoma: A Retrospective Study of 100 Patients in Brazil

Andre Meireles

Poster Presenter: Andre Meireles

$Thumbnail for Clinically Relevant Subgroup Analysis From the Randomized Phase 3 EPCORE FL-1 Trial: Treatment (Tx) Effect of Epcoritamab (E) With Lenalidomide and Rituximab (R2) in Relapsed/Refractory Follicular Lymphoma (R/R FL)$

IBCL - 1506

Clinically Relevant Subgroup Analysis From the Randomized Phase 3 EPCORE FL-1 Trial: Treatment (Tx) Effect of Epcoritamab (E) With Lenalidomide and Rituximab (R2) in Relapsed/Refractory Follicular Lymphoma (R/R FL)

Bradley Hunter

Poster Presenter: Bradley Hunter

Video

$Thumbnail for Efficacy of BRAF Inhibitors Plus Rituximab in Relapsed or Refractory Hairy Cell Leukemia: A Systematic Review and Meta-Analysis$

IBCL - 1525

Efficacy of BRAF Inhibitors Plus Rituximab in Relapsed or Refractory Hairy Cell Leukemia: A Systematic Review and Meta-Analysis

Deepika Reddy Aluru

Poster Presenter: Deepika Reddy Aluru

Thumbnail for Sociodemographic Factors and Treatment Patterns Associated With Overall Survival in Splenic Marginal Zone Lymphoma: A Nationwide Retrospective Cohort Study (2000-2022)

IBCL - 1540

Sociodemographic Factors and Treatment Patterns Associated With Overall Survival in Splenic Marginal Zone Lymphoma: A Nationwide Retrospective Cohort Study (2000-2022)

Manas Pustake

Poster Presenter: Manas Pustake

Thumbnail for Concomitant Proton Pump Inhibitors Do Not Worsen Immune Checkpoint Inhibitor Outcomes Despite a Prognostically Unfavorable Baseline BMI Imbalance: A Real-World Confounder Analysis

IBCL - 1560

Concomitant Proton Pump Inhibitors Do Not Worsen Immune Checkpoint Inhibitor Outcomes Despite a Prognostically Unfavorable Baseline BMI Imbalance: A Real-World Confounder Analysis

Disha Patel

Poster Presenter: Disha Patel

IBCL - 1632

Clinicodemographic Predictors of Outcome in Lymphoplasmacytic Lymphoma: Insights From a SEERStat Multivariate Model

Hassan Ali

Poster Presenter: Hassan Ali

Thumbnail for Life Expectancy of Hairy Cell Leukemia Patients Approaches General Population: An Updated Analysis of 5669 Cases from SEER Database (1978-2020)

IBCL - 1715

Life Expectancy of Hairy Cell Leukemia Patients Approaches General Population: An Updated Analysis of 5669 Cases from SEER Database (1978-2020)

Alamin Mustafa

Poster Presenter: Alamin Mustafa

Thumbnail for Real-World Outcomes of Bendamustine & Rituximab With or Without Maintenance Rituximab in Follicular Lymphoma: A TriNetX Analysis

IBCL - 1764

Real-World Outcomes of Bendamustine & Rituximab With or Without Maintenance Rituximab in Follicular Lymphoma: A TriNetX Analysis

Anuja Abhyankar

Poster Presenter: Anuja Abhyankar

Thumbnail for Noncancer Competing Mortality in Follicular Lymphoma: Cardiovascular, Infectious, and Second Malignancy Deaths in a Population-Based Cohort, SEER 2000-2022

IBCL - 184

Noncancer Competing Mortality in Follicular Lymphoma: Cardiovascular, Infectious, and Second Malignancy Deaths in a Population-Based Cohort, SEER 2000-2022

Yasir Aziz

Poster Presenter: Yasir Aziz